Aleksandra Zivkovic Selected Research

Hematologic Neoplasms (Hematological Malignancy)

1/2022	Ceramide synthase 6 impacts T-cell allogeneic response and graft-versus-host disease through regulating N-RAS/ERK pathway.
5/2017	Ceramide synthesis regulates T cell activity and GVHD development.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Aleksandra Zivkovic Research Topics

Disease

5	Neoplasms (Cancer) 09/2023 - 02/2012
3	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2021 - 10/2014
2	Hematologic Neoplasms (Hematological Malignancy) 01/2022 - 05/2017
2	Inflammation (Inflammations) 01/2022 - 05/2017
2	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2022 - 05/2017
2	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2021 - 03/2018
2	Multiple Sclerosis 01/2021 - 10/2014
2	Autoimmune Diseases (Autoimmune Disease) 09/2020 - 10/2014
2	Pain (Aches) 04/2020 - 06/2015
2	Relapsing-Remitting Multiple Sclerosis 01/2016 - 10/2014
1	Breast Neoplasms (Breast Cancer) 01/2022
1	Leukemia 01/2022
1	Cognitive Dysfunction 01/2021
1	Narcolepsy 01/2021
1	Encephalomyelitis (Myeloencephalitis) 09/2020
1	Asthma (Bronchial Asthma) 04/2020
1	Obesity 04/2020
1	Parkinson Disease (Parkinson's Disease) 03/2018
1	Metabolic Diseases (Metabolic Disease) 08/2015
1	Wounds and Injuries (Trauma) 06/2015
1	Neuralgia (Stump Neuralgia) 06/2015
1	Myocardial Stunning (Stunned Myocardium) 07/2013
1	Takotsubo Cardiomyopathy 07/2013
1	Heart Arrest (Cardiac Arrest) 07/2013

Drug/Important Bio-Agent (IBA)

5	Fingolimod Hydrochloride (FTY720)FDA Link 01/2021 - 10/2014
3	CeramidesIBA 09/2023 - 02/2012
3	LigandsIBA 09/2020 - 03/2018
2	dihydroceramide desaturaseIBA 09/2023 - 01/2022
2	Histamine H3 Receptors (Histamine H3 Receptor)IBA 12/2021 - 01/2021
2	Sphingosine-1-Phosphate ReceptorsIBA 01/2021 - 06/2015
2	7a- (4- octylphenethyl)tetrahydro- 1H- oxazolo(3,4- c)oxazoleIBA 01/2016 - 10/2014
1	Biomarkers (Surrogate Marker)IBA 09/2023
1	LipidsIBA 09/2023
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2023
1	EnzymesIBA 01/2023
1	eliglustatIBA 01/2023
1	Ether (Diethyl Ether)IBA 01/2022
1	c-Mer Tyrosine KinaseIBA 01/2022
1	CDPdiacylglycerol-Serine O-PhosphatidyltransferaseIBA 01/2022
1	PhosphatidylserinesIBA 01/2022
1	pitolisantIBA 01/2021
1	Histamine (Histamine Dihydrochloride)FDA Link 01/2021
1	piperidineIBA 01/2021
1	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 01/2021
1	AntigensIBA 09/2020
1	siponimodIBA 09/2020
1	MorpholinosIBA 09/2020
1	imidazoleIBA 04/2020
1	indacrinoneIBA 03/2018
1	Monoamine Oxidase (MAO)IBA 03/2018
1	sphingosine kinaseIBA 01/2016
1	ResveratrolIBA 08/2015
1	TubulinIBA 08/2015
1	FTY 720PIBA 06/2015
1	Paclitaxel (Taxol)FDA LinkGeneric 06/2015
1	OxazolesIBA 10/2014
1	7a- (4- (heptyloxy)phenethyl)tetrahydro- 1H- oxazolo(3,4- c)oxazoleIBA 10/2014

Therapy/Procedure

3	Therapeutics 09/2023 - 10/2014
2	Immunotherapy 01/2022 - 05/2017
2	Cell Transplantation 01/2022 - 05/2017
1	Drug Therapy (Chemotherapy) 06/2015
1	General Anesthesia 07/2013